0001127602-18-034303.txt : 20181126
0001127602-18-034303.hdr.sgml : 20181126
20181126162238
ACCESSION NUMBER: 0001127602-18-034303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181121
FILED AS OF DATE: 20181126
DATE AS OF CHANGE: 20181126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Lynne
CENTRAL INDEX KEY: 0001631667
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 181201095
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD.
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-11-21
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001631667
Powell Lynne
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - CCO
Common Stock
2018-11-21
4
M
0
12000
3.22
A
14455
D
Common Stock
2018-11-21
4
S
0
12000
9.06
D
2455
D
Common Stock
2018-11-21
4
S
0
2455
9.01
D
0
D
Emp. Stock Option (Right to Buy)
3.22
2018-11-21
4
M
0
12000
0
D
2017-05-23
2026-05-23
Common Stock
12000
101427
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018.
The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $8.80 to $9.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes, by power of attorney
2018-11-26